Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-20-035688
Filing Date
2020-11-09
Accepted
2020-11-09 06:04:40
Documents
1
Group Members
DANIEL B. ASHERMITCHELL P. KOPIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea129511-13gintra_titanpharm.htm SC 13G 62087
  Complete submission text file 0001213900-20-035688.txt   63651
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46083 | Film No.: 201295962
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 245 PALM TRAIL DELRAY BEACH FL 33483
Business Address 245 PALM TRAIL DELRAY BEACH FL 33483 8475629030
INTRACOASTAL CAPITAL, LLC (Filed by) CIK: 0001646799 (see all company filings)

EIN.: 320460881 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G